{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T15:51:30Z","timestamp":1781797890310,"version":"3.54.5"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:00:00Z","timestamp":1781740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:00:00Z","timestamp":1781740800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Abiogen Pharma spa","award":["This research was funded by Abiogen Pharma Spa. The funder played no decision-making role in the design"],"award-info":[{"award-number":["This research was funded by Abiogen Pharma Spa. The funder played no decision-making role in the design"]}]},{"name":"Abiogen Pharma spa","award":["execution"],"award-info":[{"award-number":["execution"]}]},{"name":"Abiogen Pharma spa","award":["analysis or reporting."],"award-info":[{"award-number":["analysis or reporting."]}]},{"DOI":"10.13039\/501100007052","name":"Universit\u00e0 degli Studi di Verona","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007052","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Osteoporos"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>\n                      <jats:italic>Summary<\/jats:italic>\n                    <\/jats:title>\n                    <jats:p>Fragility fractures are frequently under-recognized in emergency departments. A survey of 34 professionals revealed inconsistent assessment of key risk factors. Relevant gaps emerged between awareness and routine practice across professional roles. These findings highlight opportunities to improve recognition, documentation, and secondary prevention in ED settings.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Fragility fractures are often under-recognized in the emergency setting, where the absence of standardized procedures leads to missed opportunities for diagnosis and secondary prevention. This project aimed to explore current emergency department (ED) practices regarding the identification and management of fragility fractures.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A qualitative, cross-sectional survey was conducted among 34 healthcare professionals (10 emergency physicians, 11 radiologists, and 13 emergency nurses) from various Italian regions. The questionnaire, developed by a multidisciplinary expert panel, investigated propensities and self-reported practices related to fracture assessment, risk factor identification, and diagnosis of fragility fracture. All responses were grouped by role and represented graphically. Findings were then discussed during an expert meeting with the same panel.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Survey data revealed a generally high level of self-reported awareness of fragility risk factors among ED professionals but inconsistent implementation of the necessary diagnostic workup in daily practice. Important indicators, such as prior fractures, history of falls, family history of hip fracture, and use of risky medications, were often under-assessed. The term \u201cfragility fracture\u201d at discharge from the ED was rarely used, and role-based discrepancies emerged in risk assessment practices.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This survey highlights relevant gaps between awareness and clinical practice in the identification of fragility fractures in the emergency setting. Improving consistency in risk assessment and documentation may represent a key step toward optimizing secondary prevention and standardizing fragility fracture management in EDs.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11657-026-01684-y","type":"journal-article","created":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T14:52:01Z","timestamp":1781794321000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Under-recognized, under-referred: a multidisciplinary evaluation of fragility fracture management in the emergency setting"],"prefix":"10.1007","volume":"21","author":[{"given":"Francesco","family":"Bertoldo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"De Iaco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Trevisan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Marcellusi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ombretta","family":"Viapiana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovannella","family":"Baggio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"De Conti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferdinando","family":"Silveri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Cocorocchio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandro","family":"Giannini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,18]]},"reference":[{"key":"1684_CR1","doi-asserted-by":"publisher","DOI":"10.1007\/s11657-025-01551-2","volume":"20","author":"P S\u00e1ez-L\u00f3pez","year":"2025","unstructured":"S\u00e1ez-L\u00f3pez P, Aldecoa \u00c1lvarez-Santullano C, Arboiro-Pinel R et al (2025) Recommendations for the prevention of fragility fractures: a consensus from international experts and Ibero-American scientific societies. Arch Osteoporos 20:76. https:\/\/doi.org\/10.1007\/s11657-025-01551-2","journal-title":"Arch Osteoporos"},{"key":"1684_CR2","doi-asserted-by":"publisher","DOI":"10.1093\/jbmrpl\/ziae038","volume":"8","author":"LE Jackson","year":"2024","unstructured":"Jackson LE, Skains RM, Mudano A et al (2024) An emergency department-based system intervention to improve osteoporosis screening for older adults at high-risk of fracture. JBMR Plus 8:ziae038. https:\/\/doi.org\/10.1093\/jbmrpl\/ziae038","journal-title":"JBMR Plus"},{"key":"1684_CR3","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.1007\/s40520-021-01844-9","volume":"33","author":"MK Javaid","year":"2021","unstructured":"Javaid MK (2021) Efficacy and efficiency of fracture liaison services to reduce the risk of recurrent osteoporotic fractures. Aging Clin Exp Res 33:2061\u20132067. https:\/\/doi.org\/10.1007\/s40520-021-01844-9","journal-title":"Aging Clin Exp Res"},{"key":"1684_CR4","doi-asserted-by":"publisher","DOI":"10.1007\/s11657-020-00736-1","volume":"15","author":"DJ Scholten","year":"2020","unstructured":"Scholten DJ, Bray JK, Wang KY et al (2020) Implementation of a fracture liaison service and its effects on osteoporosis treatment adherence and secondary fracture at a tertiary care academic health system. Arch Osteoporos 15:80. https:\/\/doi.org\/10.1007\/s11657-020-00736-1","journal-title":"Arch Osteoporos"},{"key":"1684_CR5","doi-asserted-by":"publisher","DOI":"10.1007\/s11657-013-0136-1","volume":"8","author":"E Hernlund","year":"2013","unstructured":"Hernlund E, Svedbom A, Iverg\u00e5rd M et al (2013) Osteoporosis in the European Union: medical management, epidemiology and economic burden: a report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA). Arch Osteoporos 8:136. https:\/\/doi.org\/10.1007\/s11657-013-0136-1","journal-title":"Arch Osteoporos"},{"key":"1684_CR6","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/s40261-020-00904-8","volume":"40","author":"A Marcellusi","year":"2020","unstructured":"Marcellusi A, Rotundo MA, Nardone C et al (2020) Osteoporosis: economic burden of disease in Italy. Clin Drug Investig 40:449\u2013458. https:\/\/doi.org\/10.1007\/s40261-020-00904-8","journal-title":"Clin Drug Investig"},{"key":"1684_CR7","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1007\/s00198-015-3277-9","volume":"27","author":"J Leal","year":"2016","unstructured":"REFReSH study group, Leal J, Gray AM et al (2016) Impact of hip fracture on hospital care costs: a population-based study. Osteoporos Int 27:549\u2013558. https:\/\/doi.org\/10.1007\/s00198-015-3277-9","journal-title":"Osteoporos Int"},{"key":"1684_CR8","doi-asserted-by":"publisher","first-page":"285","DOI":"10.2340\/16501977-2310","volume":"50","author":"W Cheung","year":"2018","unstructured":"Cheung W, Shen W, Dai D et al (2018) Evaluation of a multidisciplinary rehabilitation programme for elderly patients with hip fracture: a prospective cohort study. J Rehabil Med 50:285\u2013291. https:\/\/doi.org\/10.2340\/16501977-2310","journal-title":"J Rehabil Med"},{"key":"1684_CR9","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.74065","author":"S Locke","year":"2024","unstructured":"Locke S, Doonan J, Jones B (2024) Advancements in the management of fragility fractures in orthopaedic patients. Cureus. https:\/\/doi.org\/10.7759\/cureus.74065","journal-title":"Cureus"},{"key":"1684_CR10","doi-asserted-by":"publisher","first-page":"117","DOI":"10.2147\/CIA.S85551","volume":"12","author":"S Walters","year":"2017","unstructured":"Walters S, Khan T, Ong T, Sahota O (2017) Fracture liaison services: improving outcomes for patients with osteoporosis. CIA 12:117\u2013127. https:\/\/doi.org\/10.2147\/CIA.S85551","journal-title":"CIA"},{"key":"1684_CR11","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1007\/s40618-023-02219-9","volume":"47","author":"M Schini","year":"2023","unstructured":"Schini M, Johansson H, Harvey NC et al (2023) An overview of the use of the fracture risk assessment tool (FRAX) in osteoporosis. J Endocrinol Invest 47:501\u2013511. https:\/\/doi.org\/10.1007\/s40618-023-02219-9","journal-title":"J Endocrinol Invest"},{"key":"1684_CR12","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.1007\/s40618-023-02082-8","volume":"46","author":"G Adami","year":"2023","unstructured":"Adami G, Biffi A, Porcu G et al (2023) A systematic review on the performance of fracture risk assessment tools: FRAX, DeFRA, FRA-HS. J Endocrinol Invest 46:2287\u20132297. https:\/\/doi.org\/10.1007\/s40618-023-02082-8","journal-title":"J Endocrinol Invest"},{"key":"1684_CR13","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1080\/09513590.2017.1407308","volume":"34","author":"G Bonaccorsi","year":"2018","unstructured":"Bonaccorsi G, Messina C, Cervellati C et al (2018) Fracture risk assessment in postmenopausal women with diabetes: comparison between DeFRA and FRAX tools. Gynecol Endocrinol 34:404\u2013408. https:\/\/doi.org\/10.1080\/09513590.2017.1407308","journal-title":"Gynecol Endocrinol"},{"key":"1684_CR14","doi-asserted-by":"publisher","first-page":"71","DOI":"10.4081\/reumatismo.2020.1267","volume":"72","author":"G Adami","year":"2020","unstructured":"Adami G, Giollo A, Rossini M et al (2020) Different fracture risk profile in patients treated with anti-osteoporotic drugs in real-life. Reumatismo 72:71\u201374. https:\/\/doi.org\/10.4081\/reumatismo.2020.1267","journal-title":"Reumatismo"},{"key":"1684_CR15","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1007\/s40618-023-02222-0","volume":"47","author":"G Porcu","year":"2023","unstructured":"Porcu G, Biffi A, Ronco R et al (2023) Refracture following vertebral fragility fracture when bone fragility is not recognized: summarizing findings from comparator arms of randomized clinical trials. J Endocrinol Invest 47:795\u2013818. https:\/\/doi.org\/10.1007\/s40618-023-02222-0","journal-title":"J Endocrinol Invest"},{"key":"1684_CR16","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s00198-012-2074-y","volume":"24","author":"JA Kanis","year":"2013","unstructured":"Kanis JA, McCloskey EV, Johansson H et al (2013) European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int 24:23\u201357. https:\/\/doi.org\/10.1007\/s00198-012-2074-y","journal-title":"Osteoporos Int"},{"key":"1684_CR17","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1007\/s00198-020-05294-3","volume":"31","author":"RL Barron","year":"2020","unstructured":"Barron RL, Oster G, Grauer A et al (2020) Determinants of imminent fracture risk in postmenopausal women with osteoporosis. Osteoporos Int 31:2103\u20132111. https:\/\/doi.org\/10.1007\/s00198-020-05294-3","journal-title":"Osteoporos Int"},{"key":"1684_CR18","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.jocd.2011.05.014","volume":"14","author":"ES Leib","year":"2011","unstructured":"Leib ES, Saag KG, Adachi JD et al (2011) Official positions for FRAX\u00ae clinical regarding glucocorticoids: the impact of the use of glucocorticoids on the estimate by FRAX\u00ae of the 10 year risk of fracture. J Clin Densitom 14:212\u2013219. https:\/\/doi.org\/10.1016\/j.jocd.2011.05.014","journal-title":"J Clin Densitom"},{"key":"1684_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbo.2025.100694","volume":"53","author":"P Hadji","year":"2025","unstructured":"Hadji P, Aapro M, Al-Dagri N et al (2025) Management of aromatase inhibitor-associated bone loss (AIBL) in women with hormone-sensitive breast cancer: an updated joint position statement of the IOF, CABS, ECTS, IEG, ESCEO, IMS, and SIOG. J Bone Oncol 53:100694. https:\/\/doi.org\/10.1016\/j.jbo.2025.100694","journal-title":"J Bone Oncol"},{"key":"1684_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1137671","author":"G Corrao","year":"2023","unstructured":"Corrao G, Biffi A, Porcu G et al (2023) Executive summary: Italian guidelines for diagnosis, risk stratification, and care continuity of fragility fractures 2021. Front Endocrinol. https:\/\/doi.org\/10.3389\/fendo.2023.1137671","journal-title":"Front Endocrinol"},{"key":"1684_CR21","doi-asserted-by":"publisher","first-page":"3345","DOI":"10.1210\/clinem\/dgad345","volume":"108","author":"M Wang","year":"2023","unstructured":"Wang M, Seibel MJ (2023) Approach to the patient with bone fracture: making the first fracture the last. J Clin Endocrinol Metab 108:3345\u20133352. https:\/\/doi.org\/10.1210\/clinem\/dgad345","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Archives of Osteoporosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11657-026-01684-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11657-026-01684-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11657-026-01684-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T14:52:02Z","timestamp":1781794322000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11657-026-01684-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,18]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1684"],"URL":"https:\/\/doi.org\/10.1007\/s11657-026-01684-y","relation":{},"ISSN":["1862-3514"],"issn-type":[{"value":"1862-3514","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,18]]},"assertion":[{"value":"14 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Francesco Bertoldo received consultation and advisory fees from Sandoz, Theramex, Amgen, and UCB pharma and speaking and lecture fees from Abiogen, Amgen, Chiesi, Alexion, and Theramex. Fabio De Iaco, Carlo Trevisan, Andrea Marcellusi, Ombretta Viapiana, Giovannella Baggio, Giorgio De Conti, Ferdinando Silveri, Antonella Cocorocchio, and Sandro Giannini declare that they have no competing financial interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}],"article-number":"93"}}